Agenus (AGEN) FCF Margin Growth (3y) (2013 - 2026)

Agenus (AGEN) FCF Margin Growth (3y) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -1,272.00
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -2,228.00
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 9,545.00
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -7.75 Mn
7 Royalty Pharma 33.72 Bn 35.84 Bn - -3,088.00
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 4,612.00
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 14,060.00
10 Agenus 311.95 Mn 286.43 Mn 34.52 Mn 15,641.00

Historic Data

Download Data
DateValue
Jun 30, 2026 15,641.00
Mar 31, 2026 15,703.00
Dec 31, 2025 -14,641.00
Sep 30, 2025 8,380.00
Jun 30, 2025 15,766.00
Mar 31, 2025 11,301.00
Dec 31, 2024 1,541.00
Sep 30, 2024 -26,378.00
Jun 30, 2024 37,456.00
Mar 31, 2024 22,992.00
Dec 31, 2023 6,802.00
Sep 30, 2023 -6,339.00
Jun 30, 2023 -11,057.00
Mar 31, 2023 -3,388.00
Dec 31, 2022 19,299.00
Sep 30, 2022 2,434.00
Jun 30, 2022 -1,806.00
Mar 31, 2022 -31,346.00
Dec 31, 2021 48,637.00
Sep 30, 2021 23,836.00